Details for 2012183760

Up to date per 22.04.2026

Actions

Title / Product Name

Krebsmarker und therapeutisches Target

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2012183760

EP Publication Number

2535716

E-Number

842361

Language

PCT Number

Publication Date

19.12.2012 A

02.11.2016 B1

Registration Date

02.11.2016

AT Publication Date

15.11.2016

Application Date

18.09.2008

Registration Number

Priorities

18.09.2007

0718167

IPC

G01N 33/574 20060101AFI20130207BHEP

Maximum Duration of Protection

18.09.2028

Owner

Cancer Research Technology LimitedAngel Building 407 St John Street London EC1V 4ADGB

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

Slettenaar, Violetc/o Institute of Cancer Queen Mary University of London Charterhouse Square London EC1M 6BQGB

Wilson, Juliac/o Institute of Cancer Queen Mary University of London Charterhouse Square London EC1M 6BQGB

Wang, Yaohec/o Institute of Cancer Queen Mary University of London Charterhouse Square London EC1M 6BQGB

Schioppa, Tizianac/o Institute of Cancer Queen Mary University of London Charterhouse Square London EC1M 6BQGB

Balkwill, Francesc/o Institute of Cancer Queen Mary University of London Charterhouse Square London EC1M 6BQGB